Altimmune, Inc.
ALT
DELAYED 1 MONTH

10 insider filings · Latest: May 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 6, 2026Mar 9 11:05 AMGregory L WeaverChief Financial Officer
Purchase
5,000$3.54$17.7K28,078(D)

View →

Mar 6, 2026Mar 9 11:00 AMJerome Benedict DursoDirector, President and CEO
Purchase
20,000$3.54$70.8K32,500(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 1, 2026May 1 8:23 PMTeri L LawverDirector
Grant/Award
48,800$2.8248,800(D)

View →

May 1, 2026May 1 8:20 PMCatherine A. SohnDirector
Grant/Award
48,800$2.8248,800(D)

View →

May 1, 2026May 1 8:18 PMDiane JorkaskyDirector
Grant/Award
48,800$2.8248,800(D)

View →

May 1, 2026May 1 8:16 PMKlaus SchaferDirector
Grant/Award
48,800$2.8248,800(D)

View →

May 1, 2026May 1 8:13 PMWayne PisanoDirector
Grant/Award
48,800$2.8248,800(D)

View →

May 1, 2026May 1 8:11 PMHodges PhilipDirector
Grant/Award
48,800$2.8248,800(D)

View →

May 1, 2026May 1 8:08 PMJohn GillDirector
Grant/Award
48,800$2.8248,800(D)

View →

May 1, 2026May 1 8:05 PMMitchel SayareDirector
Grant/Award
48,800$2.8248,800(D)

View →